October 2016 Vol 7, No 9
The Academy of Oncology Nurse & Patient Navigators (AONN+) is pleased to announce the 2016 Oncology Nurse Excellence™ (ONE) Award nominees.
Restoring Quality of Life and Hematologic Function with Ibrutinib in Treatment-Naive Patients with Chronic Lymphocytic Leukemia in the RESONATE-2 Study
Disease symptoms and treatment complications can profoundly affect quality of life (QOL) in patients (pts) with chronic lymphocytic leukemia (CLL). Here, we compare the QOL and hematologic function of patients treated with frontline ibr versus clb.
Prevention of Everolimus/Exemestane (EVE/EXE) Stomatitis in Postmenopausal (PM) Women with Hormone Receptor_Positive (HR+) Metastatic Breast Cancer (MBC) Using a Dexamethasone-Based Mouthwash (MW): Results of the SWISH Trial
Stomatitis is a common adverse event (AE) of mTOR inhibition. Nurses are critical in educating patients about and treatment of AEs.
Interdisciplinary Management of Chemorefractory NHL Patients Treated with KTE-C19 (Anti-CD19 CAR T Cells) in Phase 1 of the ZUMA-1 Clinical Study
Patients with chemorefractory non-Hodgkin lymphoma (NHL) have poor response to standard therapy and short overall survival. The objectives of the phase 1 ZUMA-1 trial were to evaluate the safety and efficacy of KTE-C19, an autologous, anti-CD19 chimeric antigen receptor (CAR) T-cell therapy in patients with chemorefractory NHL.
Eight Case Studies of Concurrent Pathogenic Mutations Identified in Hereditary Breast and Ovarian Cancer Gene Panel
Annette Leon, PhD, MS, FACMG, Lauren Ryan, MS, LCGC, Lilian Servais, MS, LCGC, Jeroen van den Akker, PhD
We reviewed the personal and family histories of patients found to have multiple pathogenic or likely pathogenic mutations when tested clinically for 19 genes for hereditary breast and ovarian cancer and the implications for the patient and his or her family.
Cancer clinical research is essential to producing evidence-based clinical care that offers better treatment outcomes. Yet the recruiting and consenting process for cancer clinical trials can be challenging and lead to slow-accruing clinical research and dissatisfaction.
A Novel Approach for 2-Stage Breast Reconstruction: Patient-Controlled Tissue Expansion Using the AeroForm CO2 Tissue Expander System
The tissue expansion process using standard of care, saline-filled expanders is lengthy, inconvenient, and uncomfortable and may lead women to make the decision to decline breast reconstruction. The efficacy and safety of a novel, needle-free, patient-controlled tissue expander using CO2 as the filling medium was compared with the standard of care in the US-based XPAND study.
Nora J. Barrett, BSN, RN, OCN, ONN-CG, Kristi L. Case, MS, CHES, CHW, Stacey L. Webb, MPA-HCA, BSN, RN, ONN-CG
Due to the lack of effective medical treatments for the most common type, pancreatic ductal adenocarcinoma (PDAC), early detection is imperative in treating the disease.
Standard 3.1 Patient Navigation: Developing a Community Needs Assessment (CNA) Adapted to the Veteran Population
The CNA will allow the LSCVAMC to identify barriers to cancer care and potential areas for improvement to ensure continuous quality improvement and access for our veterans with cancer.
Page 1 of 6
Results 1 - 10 of 51
Results 1 - 10 of 51